龙源期刊网 http://www.qikan.com.cn
肺脏超声（LUS）判断新生儿呼吸窘迫综合征病情程度及评估肺泡表面活性物质的价值
作者：张达玲
来源：《健康必读·下旬刊》2018年第05期
【摘 要】目的：探究肺脏超声（LUS）判断新生儿呼吸窘迫综合征病情程度及评估肺泡表面活性物质的价值。方法：选择2017年9月～12月于我院就诊的新生儿呼吸窘迫综合征患儿为研究对象，治疗前后分别给予肺脏超声判断，对肺脏超声征象和相应的评分变化进行对比。结果：新生儿呼吸窘迫综合征患儿经肺泡表面活性物质治疗后，总有效率高达100.00%，LUS评分在不同时间点均获得显著降低，用药后除之外A/APO2，其他肺功能指标均有所下降，具有统计学意义（P
【关键词】肺脏超声；新生儿呼吸窘迫综合征；病情程度；肺泡表面活性物质
Assessment of the severity of neonatal respiratory distress syndrome and the value of pulmonary surfactant by pulmonary ultrasound
Zhang Daling（Sichuan Dazhou Dazhou 635100）
Abstract Objective： To explore the value of pulmonary ultrasound （LUS） in judging the severity of neonatal respiratory distress syndrome （NRDS） and to evaluate the pulmonary surfactant. Methods： from September 2017 to December， we selected neonates with respiratory distress from September 2017 to December in our hospital. Children with syndromes were studied. Before and after treatment， the ultrasonic findings of lung and the corresponding scores were compared. Results： after the treatment of neonatal respiratory distress syndrome， alveolar
surfactant was used to treat neonatal respiratory distress syndrome. The total effective rate was as high as 100.00g / L and the score of LUS decreased significantly at different time points， except for A / P / APO _ 2 after medication. The indexes of pulmonary function were all decreased， which had statistical significance （P
Key words： Pulmonary ultrasound； neonatal respiratory distress syndrome； severity； alveolar surfactant
【中图分类号】R722.1 【文献标识码】A 【文章编号】1672-3783（2018）05-03-00-01 新生儿呼吸窘迫综合征（RDS）作为一种常见的新生儿期肺部疾病，早产儿发生的几率相对较高，临床症状以呼吸衰竭和呼吸困难为主，在一定程度上会严重威胁到新生儿的生命健康，是造成新生儿死亡的重要原因[1]。本次研究选取我院收治的新生儿呼吸窘迫综合征和肺
肺脏超声(LUS)判断新生儿呼吸窘迫综合征病情程度及评估肺泡表面活性物质的价值
